India’s Hetero Labs Ltd said it received local regulatory approval to launch its version of anti-viral drug favipiravir for the treatment of COVID-19.
The drug, priced at 59 rupees (79 US cents) per tablet, will be available at drug stores from Wednesday, privately held Hetero said.
Source:aljazeera.com
Britain and Iraq have agreed an unprecedented joint plan to tackle people smuggling gangs responsible for thousands of migrants crossing the Channel in small boats.
Australia will ban children under 16 from using social media, after its Senate approved the world’s strictest laws. The ban – which will not take
A ceasefire between Israel and Hezbollah has taken effect, aiming to end more than a year of war in Lebanon. As displaced families return home
The families of two Australian teenagers killed in a suspected methanol poisoning in Laos have welcomed news that eight people have been detained during a
2021 © Kencity Media Limited | Powered by Maxme Group
